Neoplasm of uncertain behavior of pleura
ICD-10 D38.2 is a billable code used to indicate a diagnosis of neoplasm of uncertain behavior of pleura.
Neoplasms of uncertain behavior of the pleura are abnormal growths that arise from the pleural tissue, which lines the thoracic cavity and surrounds the lungs. These neoplasms can be benign or malignant, but their uncertain behavior indicates that their potential for progression or metastasis is not clearly defined. Clinically, these neoplasms may present with symptoms such as chest pain, dyspnea, or pleuritic pain, and they may be discovered incidentally on imaging studies. Diagnosis typically involves imaging modalities such as chest X-rays, CT scans, or MRI, followed by histopathological examination through biopsy to ascertain the nature of the neoplasm. Surveillance is crucial, as these neoplasms may require monitoring for changes in size or behavior, which could indicate malignant transformation. The management of patients with pleural neoplasms of uncertain behavior often involves a multidisciplinary approach, including oncologists, pulmonologists, and thoracic surgeons, to determine the best course of action based on individual patient factors and the characteristics of the neoplasm.
Detailed clinical history, imaging results, and biopsy reports.
Patients presenting with unexplained pleuritic chest pain or incidental findings on imaging.
Ensure clear documentation of symptoms and follow-up plans to support coding.
Comprehensive treatment plans, pathology reports, and follow-up assessments.
Management of patients with diagnosed pleural neoplasms requiring chemotherapy or surgical intervention.
Documenting the decision-making process regarding treatment options and patient discussions.
Used when a pleural effusion is present and needs to be drained for diagnostic or therapeutic purposes.
Document the indication for the procedure, the amount of fluid removed, and any cytological analysis performed.
Pulmonologists should ensure that the procedure is justified based on clinical findings.
It refers to a growth that cannot be definitively classified as benign or malignant, indicating a need for careful monitoring and potential further investigation.
